08:00 , Feb 10, 2014 |  BioCentury  |  Finance

Confident roll of the dice(r)

Underwriters for Dicerna Pharmaceuticals Inc. 's IPO took the rare step of waiving a lockup period for the RNAi play - a move that could give some existing shareholders a free hand to immediately realize...
07:00 , Aug 5, 2013 |  BC Week In Review  |  Company News

Bionostics Holdings, Techne deal

Techne acquired Bionostics for about $104 million in cash. Bionostics, which develops and markets device control products to verify the operation of in vitro diagnostic (IVD) devices, reported about $29.3 million in sales for the...